"Phase 2 Southwest Oncology Group-directed intergroup trial (S0505) of sorafenib in advanced soft tissue sarcomas," Cancer (Vol: 118, Issue: 3, Page 770-776) - 2012
"A phase II study of everolimus in combination with imatinib for previously treated advanced renal carcinoma," Investigational New Drugs (Vol: 29, Issue: 2, Page 374-379) - 2011
"Safety and efficacy of sorafenib in elderly patients treated in the North American advanced renal cell carcinoma sorafenib expanded access program," Oncology (Vol: 78, Issue: 5-6, Page 340-347) - 2010
"A phase II study of paclitaxel poliglumex in combination with transdermal estradiol for the treatment of metastatic castration-resistant prostate cancer after docetaxel chemotherapy," Anti-Cancer Drugs (Vol: 21, Issue: 4, Page 433-438) - 2010
"Safety and efficacy results of the advanced renal cell carcinoma sorafenib expanded access program in North America," Cancer (Vol: 116, Issue: 5, Page 1272-1280) - 2010
"Editorial Comment," Journal of Urology (Vol: 182, Issue: 6, Page 2675-) - 2009
"Phase II study of androgen synthesis inhibition with ketoconazole, hydrocortisone, and dutasteride in asymptomatic castration-resistant prostate cancer," Clinical Cancer Research (Vol: 15, Issue: 22, Page 7099-7105) - 2009
"Phase I study of ixabepilone, mitoxantrone, and prednisone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel-based therapy: A study of the Department Of Defense Prostate Cancer Clinical Trials Consortium," Journal of Clinical Oncology (Vol: 27, Issue: 17, Page 2772-2778) - 2009
"A phase II study of high-dose calcitriol combined with mitoxantrone and prednisone for androgen-independent prostate cancer," BJU International (Vol: 102, Issue: 11, Page 1601-1606) - 2008
"Correlation of kinase genotype and clinical outcome in the North American intergroup phase III trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 study by cancer and leukemia group B and southwest oncology group," Journal of Clinical Oncology (Vol: 26, Issue: 33, Page 5360-5367) - 2008
"C-reactive protein as a prognostic marker for men with androgen-independent prostate cancer: Eesults from the ASCENT trial," Cancer (Vol: 112, Issue: 11, Page 2377-2383) - 2008
"Histologic response of dose-intense chemotherapy with preoperative hypofractionated radiotherapy for patients with high-risk soft tissue sarcomas," Cancer (Vol: 112, Issue: 11, Page 2432-2439) - 2008
"Southwest Oncology Group phase II study of irinotecan in patients with advanced transitional cell carcinoma of the urothelium that progressed after platinum-based chemotherapy," Clinical Genitourinary Cancer (Vol: 6, Issue: 1, Page 36-39) - 2008
"Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033," Journal of Clinical Oncology (Vol: 26, Issue: 4, Page 626-632) - 2008
"Managing bone loss in men with locally advanced prostate cancer receiving androgen deprivation therapy," Journal of Urology (Vol: 179, Issue: 2, Page 414-423) - 2008
"A phase 2 study of carboplatin plus docetaxel in men with metastatic hormone-refractory prostate cancer who are refractory to docetaxel," Cancer (Vol: 112, Issue: 3, Page 521-526) - 2008
"Intermittent chemotherapy in patients with metastatic androgen-independent prostate cancer: Results from ASCENT, a double-blinded, randomized comparison of high-dose calcitriol plus docetaxel with placebo plus docetaxel," Cancer (Vol: 112, Issue: 2, Page 326-330) - 2008
"Southwest oncology group phase II study of ispinesib in androgen-independent prostate cancer previously treated with taxanes," Clinical Genitourinary Cancer (Vol: 6, Issue: 2, Page 103-109) - 2008
"The hazards of intermediate endpoints," Cancer (Vol: 110, Issue: 9, Page 1877-1879) - 2007
"Diethylstilbestrol and docetaxel: A phase II study of tubulin active agents in patients with metastatic, androgen-independent prostate cancer," Cancer (Vol: 110, Issue: 5, Page 996-1002) - 2007
